Elise Morice, PhD
Affiliations: | NSERM, CNRS, UPMC, ParisI |
Google:
"Elise Morice"Mean distance: 17.01 (cluster 11) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Apazoglou K, Farley S, Gorgievski V, et al. (2018) Antidepressive effects of targeting ELK-1 signal transduction. Nature Medicine |
| Morice E, Farley S, Poirier R, et al. (2013) Defective synaptic transmission and structure in the dentate gyrus and selective fear memory impairment in the Rsk2 mutant mouse model of Coffin-Lowry syndrome. Neurobiology of Disease. 58: 156-68 |
| Morice E, Denis C, Giros B, et al. (2010) Evidence of long-term expression of behavioral sensitization to both cocaine and ethanol in dopamine transporter knockout mice. Psychopharmacology. 208: 57-66 |
| Morice E, Andreae LC, Cooke SF, et al. (2008) Preservation of long-term memory and synaptic plasticity despite short-term impairments in the Tc1 mouse model of Down syndrome. Learning & Memory (Cold Spring Harbor, N.Y.). 15: 492-500 |
| Khelfaoui M, Denis C, van Galen E, et al. (2007) Loss of X-linked mental retardation gene oligophrenin1 in mice impairs spatial memory and leads to ventricular enlargement and dendritic spine immaturity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 9439-50 |
| Morice E, Billard JM, Denis C, et al. (2007) Parallel loss of hippocampal LTD and cognitive flexibility in a genetic model of hyperdopaminergia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 2108-16 |
| Morice E, Denis C, Macario A, et al. (2005) Constitutive hyperdopaminergia is functionally associated with reduced behavioral lateralization. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 575-81 |
| Morice E, Denis C, Giros B, et al. (2004) Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background. The European Journal of Neuroscience. 20: 120-6 |